5-HTPvsMelatonin

5-HTP readily crosses the blood-brain barrier via the large neutral amino acid transporter (LAT1/SLC7A5), unlike serotonin itself which cannot. Once in the brain, aromatic L-amino acid decarboxylase (AADC, also called DOPA decarboxylase) converts 5-HTP to serotonin (5-hydroxytryptamine) using pyridoxal-5-phosphate (active vitamin B6) as a cofactor. This completely bypasses tryptophan hydroxylase (TPH2), the rate-limiting enzyme in the normal serotonin synthesis pathway from dietary L-tryptophan. The result is a reliable, dose-dependent increase in serotonin across multiple brain regions including the dorsal raphe nucleus, hippocampus, and prefrontal cortex. Elevated serotonin activates 5-HT1A autoreceptors (calming), 5-HT2A/2C postsynaptic receptors (mood modulation), and 5-HT3 receptors (gut-brain signaling). In the pineal gland, serotonin is converted by arylalkylamine N-acetyltransferase (AANAT) to N-acetylserotonin, then by hydroxyindole O-methyltransferase (HIOMT) to melatonin — explaining the sleep-promoting effects.

Melatonin binds to G-protein-coupled MT1 and MT2 receptors, which are densely expressed in the suprachiasmatic nucleus (SCN) of the hypothalamus—the brain's master circadian pacemaker. MT1 activation couples to Gi/o proteins, inhibiting adenylyl cyclase and reducing cAMP, which suppresses SCN neuronal firing and promotes sleepiness. MT2 activation modulates cGMP signaling and phase-shifts the circadian rhythm (useful for jet lag and shift work). Melatonin also has direct antioxidant properties, scavenging hydroxyl and peroxyl radicals in mitochondria and upregulating antioxidant enzymes like glutathione peroxidase. It supports immune function through modulation of T-cell cytokine production and may act at MT3 (quinone reductase 2) binding sites. Low doses are often more effective because they mimic physiological nighttime levels.